Amyloid accumulation in the brain is the major pathological hallmark of Alzheimer disease (AD).
| INTRODUCTION
Alzheimer disease (AD) is a progressive neurodegenerative disease, characterized by memory loss and cognitive decline. AD brain pathology includes intracellular aggregation of amyloid beta (Aβ) peptide and tau protein, and accumulation of extracellular Aβ plaques. 1 Previously, extracellular fibrillar Aβ was considered as the main toxic species. Nevertheless, it has become increasingly clear that soluble oligomeric Aβ (oAβ) aggregates play important roles in the pathogenesis of AD; thus, the original amyloid cascade hypothesis has been replaced by the oligomer hypothesis. [2] [3] [4] Soluble oAβ appears early in the pathology of AD, and may influence cognitive function at young ages by disturbing choline uptake processes. 3 These Aβ 42 oligomer accumulations within neuronal processes and synaptic profiles correlate strongly with pathological alterations in Tg2576 mouse and human AD brains. 5, 6 Regarding microglia, there is abundant evidence that brain microglial cells have the capability to participate in both phagocytosis and clearance of Aβ, [7] [8] [9] [10] [11] [12] but the mechanism by which the activated microglial cells help to remove and internalize Aβ deposits is currently unclear.
Autophagy and endocytosis provide nutrients and macromolecules for the cell from internal and external resources, respectively.
They share a common terminus-lysosomal degradation. Autophagosomes also fuse with endosomes, forming organelles called "amphi-
somes" before fusion with lysosomes. 13, 14 Several regulators are implicated in the main stages of the autophagy/endocytosis process.
Autophagosome formation requires the class III phosphatidylinositol 3-kinase (PtdIns3K) complex and two ubiquitin-like (Ubl) conjugation systems, Atg12-Atg5-Atg16 and Atg8-PE. 15 During endosome maturation, Rab5 is replaced by Rab7 in a highly co-ordinated process referred to as Rab conversion. 16 In addition, LAMP1/2, V-ATPase and
Cathepsins are involved in lysosomal degradation. [17] [18] [19] [20] Recently, the transcription factor EB (TFEB), a regulator of lysosomal biogenesis, has been the focus of many investigations. [21] [22] [23] [24] Suppression of the mechanistic target of rapamycin complex 1 (mTORC1) causes nuclear translocation of TFEB, which activates genes involved in autophagy and lysosomal function. 14, 24, 25 Aβ is taken up by endosomes, which ultimately fuse with autophagosomes/lysosomes for degradation. 26, 27 Several studies have suggested that Aβ decreases the microtubuleassociated protein light chain 3 (LC3)-II/I ratio and/or increases sequestosome 1 (SQSTM1) (p62), indicating that Aβ can disrupt normal autophagic flux. 28, 29 Another study showed that TFEB overexpression restored the expression of LAMP2 and Rab7 in Aβ 1-42 -treated SH-SY5Y cells, suggesting that Aβ impacts lysosomal function. 30 Aβ induced a dose-dependent reduction of the TFEB in the nucleus of the primary microglia, along with the inadequate lysosomal acidification. 31 Although the influence of oAβ on the endosomalautophagy-lysosomal system has been the subject of some current studies, the underlying mechanisms remain largely elusive.
Pseudoginsenoside-F11 (PF11), an ocotillol-type saponin, was isolated from leaves of Panax pseudoginseng subsp. himalaicus H ARA (Himalayan Panax). 32 Our previous studies have shown that PF11 has beneficial effects in vitro and in vivo on central nervous system disorders, such as Parkinson disease (PD) and AD. 33, 34 PF11 protected SH-SY5Y cells and primary neurons from the damage induced by the conditioned medium of activated microglia. The neuroprotective effects of PF11 were partly due to its inhibition of microglial activation by downregulating TLR4-mediated TAK1/IKK/NF-kB, MAPKs and Akt signaling pathways. 34 In particular, we found that PF11 significantly inhibited the expression of β-amyloid precursor protein (APP) and Aβ in the brains of APP/PS1 mice, and microglial cells were clustered around the amyloid plaques. 33 However, the effects of PF11 on accumulation of Aβ are still unknown.
The present data showed that high-concentration oAβ was able to interrupt the autophagy-lysosomal degradative system by regulating TFEB nuclear translocation and delaying Rab conversion. PF11 facilitated oAβ clearance and reversed the dysfunction of the endosomal-lysosomal system by promoting the maturation of endosomes and restoring the lysosomal function in microglia.
2 | RESULTS
| PF11 causes an increase in oligomeric Aβ uptake and degradation
To determine the effect of PF11 on the Aβ uptake, primary rat microglial cells were pretreated with increasing concentrations of PF11 for 24 hours, then, incubated with 5 μM oAβ for 3 hours at 37 C. At the end of incubation, cells were imaged using confocal microscopy and media plus cells were collected for western blot analysis. Confocal microscopy and western blot analysis have shown that intracellular Aβ accumulation was enhanced by pretreatment with PF11 in a concentration-dependent manner ( Figure 1A-C) . In parallel, the levels of residual trimers and tetramers of Aβ in the media were lowered by PF11 ( Figure 1D) . The above mentioned results demonstrated that PF11 could promote the uptake of oAβ. We then investigated the effects of PF11 on Aβ degradation. Microglia were incubated with 5 μM oAβ for 4 hours, then the cells were washed and treated with PF11 (0-100 μM) for 2 hours. The western blotting results revealed that the Aβ levels in the medium before the washout did not change among all the groups ( Figure 1H ). The confocal imaging and western blotting results revealed that the intracellular level of oAβ was significantly decreased in the cells treated with 30 and 100 μM PF11 compared with controls ( Figure 1E-G) . In addition, the microglial cells treated with PF11 (1-100 μM) and/or oAβ (5 μM) for 24 hours did not show reduction in viability ( Figure S1B ), excluding the cytotoxicity of PF11 and oAβ. Moreover, in our results, the mTOR inhibitor rapamycin enhanced the uptake of oAβ, but had no effect on degradation. These data suggested that PF11-enhanced oAβ removal by promoting the uptake and degradation of oAβ and these effects might be partly related to mTOR pathways, which we demonstrate further below.
| PF11 improves lysosomal function and promoting nuclear transportation of TFEB
We sought to confirm whether the autophagy-lysosome pathway was involved in mediating the PF11-induced increase in oAβ uptake and degradation. Low concentrations of oAβ increased the protein levels of Vps34, Beclin 1, ATG5 and LC3II. Intriguingly, the levels of these proteins were not significantly different from the baseline in microglia treated with high-concentrations oAβ ( Figure S2 ). However, the expression of Vps34, Beclin 1 and ATG5 was unaffected by PF11.
Also, PF11 had no effect on the level of LC3II (a marker of autophagosomes) in microglia ( Figure S3 ). These results suggested that PF11 had no impact on the formation of autophagosomes or other signaling pathways involved in this process.
Next, to investigate whether the PF11 enhanced lysosomal function, we examined the accumulation of p62, which is an established autophagy substrate, reflects impairment of lysosome function. 35 We monitored the change of p62 in chloroquine (an inhibitor of lysosomal functions)-exposed microglia. As shown in Figure 2A , the level of p62 was significantly increased in chloroquine-treated cells, and significantly decreased by high concentrations of PF11.
To further assess the effects of PF11 on lysosomal activity, we TFEB, an important regular of lysosome biogenesis, enhances Aβ uptake and degradation in astrocytes. 23 This fact let us to hypothesize that PF11 might regulate the nuclear localization of TFEB, thereby promoting Aβ internalization and degradation. To verify this possibility, we observed TFEB nuclear localization by immunocytochemistry using confocal microscopy and examined expression of TFEB in nuclei by western blotting. First, the nuclear localization of TFEB was increased with increasing oAβ concentration ( Figure S5A ,C). However, a large number of studies have implicated defective functioning of the autophagic-lysosomal system in the pathogenesis of AD. 36 Thus, TFEB nuclear localization might be a transient event after oAβ stimulation. We therefore monitored TFEB nuclear localization in 5 μM oAβ-treated microglia at various times. As shown in Figure S5B ,D, TFEB was increasingly localized in the nucleus until 9 hours, and was sequestered in the cytoplasm after 24 hours. Accordingly, western blotting revealed a significant increase in TFEB nuclear localization in cells treated with oAβ for 9 hours ( Figure S5E ). Furthermore, confocal imaging showed that the number of microglia with TFEB localized to the nucleus was increased in the PF11-treated group compared with the oAβ-treated group ( Figure 3A,B) . The level of nuclear TFEB was also significantly increased by 30 μM PF11, as judged by western blotting ( Figure 3C ). Recent studies have shown that mTORC1 suppression is necessary for TFEB activation. 24, 37 Figure S5F shows that phosphorylation of both p70 S6 kinase and mTOR was significantly increased when microglia were incubated with 5 μM oAβ for 24 hours, and this increase was inhibited by high concentrations of PF11 ( Figure 3D ). These results suggested that PF11 might promote mTOR-dependent TFEB-mediated lysosome biogenesis.
| PF11 influences the maturation of endosomes
The maturation of endosomes is necessary for the transport of Aβ into lysosomes for degradation. Among about 20 Rab GTPases with defined functions in endocytosis, Rab5 (early endosome marker) and Rab7 (late endosome marker) have been studied extensively.
13,38-41 Based on the above results, we hypothesized that oAβ had an effect on the maturation of endosomes, which was mediated through from the culture medium. The results had shown that the oAβ resulted in a delay of Rab conversion and PF11 restored this process. Moreover, the mTOR inhibitor rapamycin had no effect on Rab conversion ( Figures 4B,Cand S7) . We also noticed that the expression level of Rab5 protein was significantly increased by 0.5 and 1 μM oAβ, and the level of Rab7 was significantly increased by 1 μM oAβ ( Figures S6C,D) . The levels of both Rabs were significantly increased after treatment with PF11 (10, 30 and 100 μM) ( Figure 4A ). These results suggested that PF11 promoted the maturation of endosomes by regulating the small GTP-binding proteins Rab5 and Rab7.
Collectively, these results indicated that in microglia, the endosomal-autophagy-lysosomal system was interrupted by highconcentrations oAβ, while PF11 facilitated oAβ uptake and clearance most likely by promoting the maturation of endosomes, and improving the function of lysosomes ( Figure 5 ). PF11 had the ability to promote mTOR-dependent TFEB-mediated lysosome biogenesis, but the mTOR inhibitor rapamycin had no effect on oAβ uptake and Rab conversion, suggesting that PF11 alleviated oAβ induced endosomelysosome defects by unique mechanisms.
| DISCUSSION
Aβ overload is responsible for the synaptic impairment and memory decline that contributes to AD progression. 6, 43 Under pathological conditions, oAβ triggers a train of toxic synaptic events by interacting with neuronal synaptic proteins, such as α7-AChRs and NMDARs to regulate downstream signaling pathways and finally cause synaptic dysfunction and cognitive impairment. 6 In addition, oAβ is known to be the neurotoxin implicated in neuronal cell death through the apoptotic pathway in vitro. 44 Microglial cells can take up oAβ more effectively than astrocytes and neurons. 8 Consistent with the previous studies using APP/PS1 mice, 33 we found that PF11 affected the clearance of oAβ in cultured microglia. The internalization of oAβ was assessed by immunocytochemistry and western blotting. On the western blot images in our study, we only showed Aβ trimers and tetramers because other forms oAβ were present in trace quantities compared with the trimers and tetramers.
Lysosomal dysfunction has been implicated in Aβ accumulation in AD brain. [45] [46] [47] [48] In the present study, we suggested for the first time that PF11 improved lysosomal function in oAβ-treated microglia. Chloroquine, a known lysosomotropic agent, is widely used to monitor lysosomal function. 35, 49 We observed the turnover of p62 in chloroquinetreated microglia in the presence or absence of PF11. We found that PF11 reduced the consequences of lysosomal dysfunction in these cells.
Thus, PF11 might increase the clearance of oAβ by improving lysosomal function. The key biochemical feature of the lysosome is its acidic lumen. The lysosomal membrane, which contains more than FIGURE 4 Effect of PF11 on the maturation of endosomes. Cells were exposed to PF11 (0-100 μM) in the presence or absence of oAβ (5 μM) for 6 hours. A, Levels of Rab5 and Rab7 were determined by western blot. Levels of proteins were quantified with ImageJ software. Data are shown as mean AE SEM (n = 3). *P < 0.05, **P < 0.01, compared with cells treated with oAβ. B, C, 293 T/17 cells transiently cotransfected with pEGFP-Rab5 and pRFP-Rab7 were treated with indicated drugs for 6 hours, followed by imaging during the continuous uptake of oAβ (0.5 μM) from the medium at 37 C for 60 minutes. In B, one two-channel frame of a single focal plane was acquired every 2 minutes. A single frame from a typical sequence is shown at left (color coding of the markers is indicated). The endosome labeled with a white asterisk (*) is shown at the indicated times in the main panels. Scale bar, 2 μm. C, Duration of pEGFP-Rab5 on endosomes. Five endosomes were examined for each group. Data are shown as mean AE SEM (n = 3). #P < 0.05, compared with controls. *P <0.05, compared with cells treated with oAβ 20 lysosomal membrane proteins, maintains the acidification of the lysosome. 14 Multiple studies have found that about 50% of all the lysosome membrane proteins are LAMPs (LAMP1 and LAMP2), and LAMP2 has more specific functions than LAMP1. 50, 51 Furthermore, at the heart of maintaining lysosomal acidic pH is the vacuolar-type H (+)-ATPase (V-ATPase). V-ATPase serves multiple functions under physiological and pathological conditions, including pH sensing, entry of viruses and toxins, and membrane fusion at a number of intracellular sites. 52 Our results suggested that the levels of lysosomal membrane proteins (LAMP2 and V-ATPase) and CatE were not increased in microglia treated with high-concentration oAβ. Meanwhile, oAβ induced inadequate lysosomal acidification in microglia. Therefore, oAβ might impair lysosomal function at high concentrations. One notable finding of this study was that PF11 improved lysosomal function by elevating the expression of CatE, LAMP2 and V-ATPase, along with the intracellular pH steady state. The role of TFEB has been intensively studied in numerous neurodegenerative diseases, such as Huntington disease, AD and PD. 21, 53, 54 It is well recognized that TFEB drives the transcription of autophagy genes (eg, UVRAG, WIPI, MAPLC3B, SQSTM1, VPS11, VPS18 and ATG9B) and lysosomal genes (including genes encoding hydrolases, lysosomal membrane proteins and the V-ATPase complex). 24, 25 In addition, TFEB knockdown reduces caveolin-dependent endocytosis. 37 Hence, TFEB is perhaps the key regulator of the endosomal-autophagy-lysosomal system. Moreover, exogenous TFEB expression enhances Aβ clearance in astrocytes 23 and this coincides with the purpose of our study. We were therefore interested to know whether the PF11 affects TFEB activation or not. Intriguingly, PF11 promoted TFEB nuclear translocation and suppressed mTORC1 activity. The activity of mTORC1 is known to control the subcellular localization of TFEB. 37 Our data demonstrated that the expression of CatE, V-ATPase and LAMP were elevated at 10 and 30 μm PF11, but were no longer significantly elevated at 100 μm PF11.
The nuclear translocation of TFEB was similar to the change of proteins.
However, 100 μM PF11 was able to induce significantly increase of
LysoSensor staining compared to microglia treated with oAβ alone, which reagents exhibit a pH-dependent increase in fluorescence intensity upon acidification. Thus, PF11 might increase the degradation of oAβ by both TFEB-induced enhanced expressions of lysosomal genes and the intracellular pH steady state.
To explore the molecular mechanisms by which PF11 affects the maturation of endosomes, we examined the expression levels of related proteins by western blot. Based on current studies, the small GTPases are well-recognized targets in human disease and participate in the regulation of endocytosis. 38, 55 Recent studies have found that
Rab conversion is an important mechanism in endosomal maturation [56] [57] [58] and Rab-cascade mechanism harmonizes multivesicular bodies maturation with lysosome fusion. 59 Early endosomes are rich in phosphatidylinositol-phosphate (PtdIns3P), whereas late endosomes contain phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)
Proposed mechanisms of the effects of PF11 on oAβ-induced endosome-lysosome defects in microglia. TFEB-mediated autophagy and lysosomal biogenesis are inhibited by the increased activity of mTORC1 in microglia treated with high-concentration oAβ. Moreover, oAβ disturbs the fusion of autophagosomes (marked by LC3) with endosomes/lysosomes (marked by LAMP1). During endocytosis, the conversion of Rab5 to Rab7 is blocked. PF11 confers protection on the oAβ-treated microglia by improving the function of lysosomes and promoting the maturation of endosomes. TFEB, transcription factor EB; mTORC1, mechanistic target of rapamycin complex 1; LAMP1, lysosome-associated membrane protein 1; LAMP2, lysosome-associated membrane protein 2; V-ATPase, vacuolar-type H (+)-ATPase. Solid arrow, the process of Aβ uptake and degradation. Dotted arrow, mechanism mediating oAβ clearance by PF11 P2). 16 During endosome maturation, Rab5 is replaced by Rab7 in a highly co-ordinated process referred to as Rab conversion. PtdIns3P is not obviously present on late endosomes. In wild-type Caenorhabditis elegans, the RAB5 or PtdIns3P signal was stable for a short time before disappearing quickly. RAB7 progressively appeared on early endosomes, reaching a peak as the RAB5/PtdIns3P signal began to decrease. 42, 57 In our study, oAβ resulted in a delay in Rab conversion and PF11 restored this process. The mTOR inhibitor rapamycin enhanced the uptake of oAβ, but had no effect on the Rab conversion.
Combined with the effects of PF11 on lysosomal functions, PF11
facilitated Aβ clearance by unique mechanisms.
Recent reports suggested that Rab5 was significantly abolished in the hlh-30 (ortholog of TFEB in mammals) mutant C. elegans compare with wild-type strain. 60 In squamous cell carcinomas, TFEB knockdown induces an enlargement of EEA1 labeled endosomes. 61 The abovementioned studies demonstrated that TFEB might be a regula- 
| Preparation of oligomeric Aβ
Oligomeric Aβ was prepared as described by Chromy et al. 62 Briefly, The morphology of oligomeric Aβ 1-42 was routinely confirmed by atomic force microscopy ( Figure S1A ).
| Cell culture
Primary rat microglial cells were prepared as described previously. 63 Briefly, mixed glial cultures were derived from the cortices of postnatal day 1 to day 2 Wistar rats. Cortices were dissociated by 0.25% trypsin followed by trituration. Dissociated cells were maintained in DMEM with 10% fetal bovine serum (FBS) at 37 C in a 5% CO 2 humidified atmosphere. After 14-day incubation, the flasks were shaken to separate microglia from astrocytes. The purity of primary microglia was 98.5% AE 1.1%.
The 293T/17 cells were maintained in DMEM medium and supplemented with 10% FBS in a humidified incubator at 37 C with 5% 
| Transient transfection
cDNAs encoding RAB5A and RAB7A were cloned into pEGFP-C2 and pRFP-C1 vectors, respectively. Plasmid transfection was performed using Lipofectamine 2000 for 24 hours.
| Aβ uptake and degradation
To determine Aβ uptake, the microglial cells were incubated with oAβ 
| Rab conversion imaging
For high-resolution imaging of cells, images were acquired through an inverted confocal microscope (Nikon). For fast confocal live-cell imaging, cells were maintained in normal growth medium in a closed chamber with internal temperature and CO 2 control. All imaging was carried out at 37 C in 5% CO 2 on an inverted confocal laser scanning microscope. For the endosome tracing, the XYZ-time scanning mode was used. Five continuous layers were acquired in the Z-direction per time point to focus on a specific endosome. Each Z-step was normally 1 μm.
| Western blot analysis
At the end of treatments, nuclear proteins were collected with cytoplas- 
| Statistical analysis
All statistical analysis was carried out using one-way ANOVA with Tukey's posttest. Data were expressed as means AE SE of the mean (SEM). P < 0.05 was considered statistically significant.
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